English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2537249      線上人數 : 225
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/6850


    題名: 抗流行性感冒病毒(H1N1)天然藥物之探索-訶子
    Studies on the natural medicines for anti-influenza virus (H1N1) -Terminalia chebula
    作者: 王秀帆
    Hsiu-Fan Wang
    貢獻者: 生藥學研究所
    關鍵詞: 訶子
    單寧
    抗流行性感冒病毒
    Chebulae fructus
    Tannin
    Anti-influenza virus
    日期: 2009
    上傳時間: 2009-09-15 17:24:58 (UTC+8)
    摘要: 本研究為尋求抗流行性感冒病毒(H1N1)藥物,進行訶子成分之分離及抗病毒活性測試,追蹤其有效活性成分。研究內容包括:一、化學探討- 由含水丙酮萃取物,經由大孔吸附樹脂、多葡糖聚脂及逆相層析等管柱,分離出 [1] Phenolcarboxylic acid: gallic acid (1), protocatechuic acid (2), chebulic acid (3)。 [2] Glloylglucoses: 1,6-di-O-galloyl-β-D-glucopyranose (4), 1,3,6-tri-O-galloyl-β-D-glucopyranose (5), 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (6)。 [3] Galloylshikimic acids: 4-O-galloylshikimic acid (7), 5-O-galloyl shikimic acid (8)。 [4] Ellagitannins: casuariin (9), chebulanin (10), corilagin (11), chebulagic acid (12), chebulinic acid (13), castalagin (14) 等十四個化合物。 二、抗H1N1流感病毒活性MTT測試- [ I ] 藥物及流感病毒同時加入細胞培養測試,以1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose(6)抗病毒活性最優,其細胞存活率為144.5 %,高於ribavirin (105.0 %)的效果,MIC值與正對照組ribavirin同為12.5 μg/ml,其次為chebulinic acid (13), 131.8 % ,MIC值為25 μg/ml。 [ II ] 加入藥物1小時後,再加入流感病毒。 在沒有藥物的保護作用之下,其細胞受病毒感染後,細胞存活率為8.5 %,而1,2,3,4,6-penta-O-galloyl-?nβ-D-glucopyranose (6), 135.9 % 和chebulinic acid (13), 134.1 %之抗病毒活性最好,其細胞存活率比正對照組ribavirin, 112.6 %高。在細胞存活率的數據顯示,本組實驗之MIC以1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose效果最好為12.5 μg/ml,和ribavirin一樣。[ III ] 加入病毒一小時後,再加入藥物,評估治療效果。在沒有任何藥物的保護作用之下,其細胞受病毒感染後,細胞之存活率為7.9 %,正對照組ribavirin為111.6 %, 而所試驗之化合物中以chebulagic acid (12), 126.9 % 和chebulinic acid (13), 120.7 % 治療性抗病毒作用最好,高於ribavirin的作用,其次1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose(6)和castalagin (14)的細胞存活率分別為109.2 % , 110.8 % ,和ribavirin的效果一致。正對照組ribavirin之MIC為12.5 μg/ml,而以上四個有效化合物之MIC均為25 μg/ml。 結論:(1) 由化學結構與活性相互關係之探討得知,多酚性化合物對流行性感冒病毒(H1N1)之抑制、預防及治療作用,以1,2,3,4,6-penta-O-galloyl-?nβ-D-glucopyranose (6) 及chebulinic acid (13)呈現最顯著之抗病毒作用。同時,取代之galloyl或chebuloyl等acyl group,總數目之多寡將影響其活性之大小。 (2) 依化學結構分類,小分子之Phenolcarboxylic acid類化合物僅以protocatechuic acid (2)之作用較佳;Glloylglucoses類化合物則以接五個galloyl基之1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (6) 抗H1N1病毒效果最好;Galloylshikimic acids類之抑制H1N1病毒作用不明顯;Ellagitannins類化合物呈現最佳之抗H1N1作用,但糖基上若有兩個以上之OH基未接取代基時,其作用顯著下降。

    This study aimed to find out anti-H1N1 virus drugs from Terminaria chebula approached by constituents isolation of and anti-H1N1assay. The methods and results include: (1) Chemical investigation- From aqueous acetone extract, by high porous adsorbents resin, polydextran, and reverse column chromatography and fourteen compounds were isolated as following: [1] Phenolcarboxylic acid: gallic acid (1), protocatechuic acid (2), chebulic acid (3). [2] Glloylglucoses: 1,6-di-O-galloyl-β-D-glucopyranose (4), 1,3,6-tri-O-galloyl -β-D-glucopyranose (5), 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (6). [3] Galloylshikimic acids: 4-O-galloyl shikimic acid (7), 5-O-galloyl shikimic acid (8). [4] Ellagitannins: casuariin (9), chebulanin (10), corilagin (11), chebulagic acid (12), chebulinic acid (13), castalagin (14). (2) Antivirus activity tests against influenza H1N1 by MTT assay- [ I ] Drugs and virus were added to cell culture plate at the same time. The 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (6) showed the highest anti-H1N1 activity and the cell viability was 144.5 %, higher than the effect of ribavirin (105.0 %). The second is chebulinic acid(13), 131.8 % and 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (6), had equivalent activity as the positive control, ribavirin and the MIC was 12.5 μg/ml. [ II ] When treatments with or without tested drugs were added 1 hour pre-incubated with the cells before adding virus, the cells without any treatments were infected and the viability was 8.5 %. However, 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (6), 135.9 % and chebulinic acid (13), 134.1 % showed excellent protective activity and the cell viability was 144.5 %, which is higher than ribavirin (112.6 %), the positive control. The MIC of 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (6) was 12.5 μg/ml and similar to the one of ribavirin. [ III ] Add drugs to cell culture plate at 1 hr after virus added. After virus infection, if without any drug’s treatment, the cell viability is 7.9 %. Using ribavirin as positive control, the cell viability was 111.6 %. chebulagic acid (12), 126.9 % and chebulinic acid (13), 120.7 % possess the best therapeutic activity and higher activity than ribavirin for H1N1 virus infection. The second and the third are 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (6), castalagin(14) and their cell viabilities were 109.2 % and 110.8 %, respectively, the same as ribavirin. The MIC of ribavirin was 12.5 μg/ml, the MIC of four active polypenolics were 25 μg/ml. In conclusion: (1) Based on SAR discussion, the inhibition, prevention, and therapeutic effects of polyphenolics for H1N1 virus infection, both 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (6) and chebulinic acid (13) showed the most significant activity. The number of substituted galloyl or chebuloyl acyl group has impact on the activity. (2) According to chemical classification, small molecule’s phenolcarboxylic acid, protocatechuic acid (2) is the only one which show good activity; in glloylglucoses, five galloyl substituted 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (6) exhibited excellently anti-H1N1 virus activity; the activity of galloylshikimic acids were not significant; ellagitannins showed the best, but if sugar moiety remains more than two free OH residues, the anti-H1N1 virus activity would decreased significantly.
    資料類型: thesis
    顯示於類別:[生藥學研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc36KbMicrosoft Word232檢視/開啟
    摘要.pdf737KbAdobe PDF230檢視/開啟
    摘要.ppt135KbMicrosoft Powerpoint379檢視/開啟
    摘要.ps530KbPostscript114檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋